Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 21.23
-0.70 (-3.19%)
At close: May 12, 2026
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.33 billion as of May 12, 2026. Its market cap has increased by 23.81% in one year.
Market Cap
2.33B
Enterprise Value
1.63B
Revenue
209.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
21.23
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.33B, a decrease of -42.57%. That is a compound annual growth rate of -14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 2.41B | -7.97% |
| Dec 31, 2025 | 2.62B | -17.62% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Model Organisms Center | 3.13B |
| Landfar Bio-medicine | 3.12B |
| Shandong Sito Bio-technology | 2.95B |
| Jilin Jian Yisheng Pharmaceutical | 2.77B |
| Shanghai Universal Biotech | 2.76B |
| Suzhou Fushilai Pharmaceutical | 2.74B |
| Cabio Biotech (Wuhan) | 2.67B |
| Shanghai Hile Bio-Technology | 2.39B |